Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryohei Yamamoto

Showing results (141-150 of 245) with videos related to

Pageof 25
Sort By:
Plos One|August 26, 2016
Serum Uric Acid Level Predicts Progression of IgA Nephropathy in Females but Not in MalesYasuyuki Nagasawa, Ryohei Yamamoto, Tatsuya Shoji, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 12, 2010
Specialist care and improved long-term survival of dialysis patientsYoshiyuki Furumatsu, Yasuyuki Nagasawa, Ryohei Yamamoto, et al.
Journal of Robotic Surgery|September 12, 2025
Reassessment of T1a cutoff for kidney cancer in the robotic eraRyohei Yamamoto, Kazuyuki Numakura, Yu Aoyama, et al.
Nihon Jinzo Gakkai Shi|December 14, 2012
[Clinical characteristics of adult-onset minimal change nephrotic syndrome in our hospital]Daisuke Mori, Maki Shinzawa, Tomoko Namba, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2014
Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort studyMaki Shinzawa, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 8, 2009
A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN)Ryohei Yamamoto, Yasuyuki Nagasawa, Tatsuya Shoji, et al.
Clinical and Experimental Nephrology|May 7, 2014
CD16+CD56+ cells are a potential culprit for hematuria in IgA nephropathyHirotsugu Iwatani, Yasuyuki Nagasawa, Ryohei Yamamoto, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 24, 2014
ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathyJunya Teranishi, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
Neurourology and Urodynamics|June 17, 2020
Candidate genes involved in the defunctionalization and refunctionalization of the urinary bladder induced by bladder anuria and reperfusionYusuke Kisou, Takamitsu Inoue, Kazutoshi Nishijima, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2011
A candidate gene approach to genetic contributors to the development of IgA nephropathyRyohei Yamamoto, Yasuyuki Nagasawa, Tatsuya Shoji, et al.
Pageof 25

Showing results (141-150 of 245) with videos related to

Sort By:
Pageof 25
Plos One|August 26, 2016
Serum Uric Acid Level Predicts Progression of IgA Nephropathy in Females but Not in MalesYasuyuki Nagasawa, Ryohei Yamamoto, Tatsuya Shoji, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 12, 2010
Specialist care and improved long-term survival of dialysis patientsYoshiyuki Furumatsu, Yasuyuki Nagasawa, Ryohei Yamamoto, et al.
Journal of Robotic Surgery|September 12, 2025
Reassessment of T1a cutoff for kidney cancer in the robotic eraRyohei Yamamoto, Kazuyuki Numakura, Yu Aoyama, et al.
Nihon Jinzo Gakkai Shi|December 14, 2012
[Clinical characteristics of adult-onset minimal change nephrotic syndrome in our hospital]Daisuke Mori, Maki Shinzawa, Tomoko Namba, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2014
Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort studyMaki Shinzawa, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 8, 2009
A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN)Ryohei Yamamoto, Yasuyuki Nagasawa, Tatsuya Shoji, et al.
Clinical and Experimental Nephrology|May 7, 2014
CD16+CD56+ cells are a potential culprit for hematuria in IgA nephropathyHirotsugu Iwatani, Yasuyuki Nagasawa, Ryohei Yamamoto, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|January 24, 2014
ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathyJunya Teranishi, Ryohei Yamamoto, Yasuyuki Nagasawa, et al.
Neurourology and Urodynamics|June 17, 2020
Candidate genes involved in the defunctionalization and refunctionalization of the urinary bladder induced by bladder anuria and reperfusionYusuke Kisou, Takamitsu Inoue, Kazutoshi Nishijima, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2011
A candidate gene approach to genetic contributors to the development of IgA nephropathyRyohei Yamamoto, Yasuyuki Nagasawa, Tatsuya Shoji, et al.
Pageof 25